Named on one round in the feed.
Since 2023-07-11
ROUNDS
1
as lead investor
LED ROUNDS · USD
$75M
across 1 round
CO-INVESTORS
1
named beside it
Named on one round in the feed.
Since 2023-07-11
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Arthrosi They develop therapies for gout and chronic kidney disease, primarily targeting gout patients. | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $75M | 2023-07-11 | [ LEAD ] |